A04759
IntroducedNYRelates to the medical use of cannabis; repeals controlled substances therapeutic research act.
New York · Session 2025
Summary
A New York bill that has been reported out of committee relates to the medical use of cannabis and would repeal the state's controlled substances therapeutic research act. Repealing the therapeutic research act could alter the legal landscape for medical cannabis access and program administration in New York.
What
A New York bill that has been reported out of committee relates to the medical use of cannabis and would repeal the state's controlled substances therapeutic research act.
Who
patients and retailers and cultivators
Why
Repealing the therapeutic research act could alter the legal landscape for medical cannabis access and program administration in New York.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More New York Cannabis Bills
- S10113Provides that a microbusiness licensee authorized to conduct retail sales may serve as a processor and cultivator for purposes of cannabis showcase event permits.Passed
- A11606Prohibits cannabis products, or packaging or labeling for a cannabis product, that are substantially similar to or likely to create confusion with a non-cannabis product.Introduced
- S10643Relates to labor peace agreements and the cannabis industry wage board.In Committee
- S00845Prohibits drug, cannabis or alcohol testing of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing is necessary for a medical emergency.In Committee
- A11562Relates to labor peace agreements and the cannabis industry wage board.Introduced
- A10698Enacts the "cannabis supply chain integrity and anti-inversion act"; prohibits any act or omission involving illicit cannabis; provides penalties for such cannabis inversion.In Committee
- S10347Requires prospective licensees of cannabis licenses to submit a formal attestation of compliance with local zoning laws, land-use regulations, and municipal code requirements and proof of local municipal compliance to the Cannabis Control Board when applying for an OCM Cannabis license, and give municipalities the ability to request an extension of time to submit an opinion on the prospective licensee application.Introduced
- A11186Expands available enforcement actions by the office of cannabis management.Introduced
- A11217Provides that a microbusiness licensee authorized to conduct retail sales may serve as a processor and cultivator for purposes of cannabis showcase event permits.Introduced
- A11122Requires applicants for a permit, registration, or license issued by the cannabis control board to report any relevant law enforcement interactions that occur during the application review process; provides for automatic denial of such application for failure to make such report.Introduced
- A11107Increases the distance allowed between cannabis storefronts and premises for adult-use on-site consumption and school grounds and houses of worship; restricts their distance with a child day care.Introduced
- S10018Requires the cannabis board to review the five most recent years of relevant New York police department crime statistics from the precinct wherein the premises of a proposed dispensary is located and review and treat as binding the finding of any resolution passed by the community board regarding an adult-use retail dispensary license application in a city having a population of one million people or more.Introduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 18, 2026